Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075081 · ClinicalTrials.gov registry record · Phase 2
Gii'Igoshimong: Sitting With Your First Family
A Phase 2 study of Substance Use and Mental Health Issue, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07075081: Recruiting Phase 2 study of Substance Use and Mental Health Issue, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT07075081 is a Phase 2 study of Substance Use and Mental Health Issue that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 300 participants, below the 1,257-participant average among 88 other Substance Use trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07075081, a Phase 2 study of Substance Use and Mental Health Issue, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized wait-list control study is to understand the relationship between ceremony and substance use (SU), SU risk (e.g., SU severity, depressive symptoms) and protective factors (e.g., spirituality, community support). The main questions it aims to answer are: * Will adults enrolled in Gii'igoshimong show improved SU outcomes compared to those in control groups? * Will self-relevant processing networks activated during stimulus engagement increase from pre- to post- engagement in ceremony and at 6-month follow-up? Researchers will compare adults that complete Gii'igoshimong with those that do not complete Gii'igoshimong to see if health outcomes are different. After completing baseline assessments, participants will be randomized to complete Gii'igoshimong now (intervention) or after the participants have completed the 1 month and 6-month post assessments (waitlist control). All participants (intervention and waitlist control) within a cohort will complete 1 month and 6 month post assessments at the same time.
Primary Outcome
Days of substance use
Conditions Studied
Interventions
- OTHER Ceremony
Study Locations (1)
Minnesota
- Great Lakes Hub - Duluth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2029-05 |
| Phase | Phase 2 |
What NCT07075081 shows while recruiting
NCT07075081 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,257-participant average among 88 other Substance Use trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Ceremony is the first listed.
NCT07075081 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07075081 about?
NCT07075081 is a clinical study titled "Gii'Igoshimong: Sitting With Your First Family". The goal of this randomized wait-list control study is to understand the relationship between ceremony and substance use (SU), SU risk (e.g., SU severity, depressive symptoms) and protective factors (e.g., spirituality, community support). The main questions it aims to answer are: * Will adults enr...
What is the current status of trial NCT07075081?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2025-09-09. Estimated completion is 2029-05.
What conditions does trial NCT07075081 study?
This clinical trial studies the following conditions: Substance Use, Mental Health Issue.
What interventions are being tested in trial NCT07075081?
The interventions under investigation include: Ceremony (OTHER).
Who is sponsoring clinical trial NCT07075081?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07075081 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07075081's enrollment target sits among peer trials
300 31st of 88 higher than 54 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Parenting in 2 Worlds Multisite Trial
RECRUITING · Phase 2
-
Ketamine for Methamphetamine Use Disorder
RECRUITING · Phase 2
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI